UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
A review of gene therapy for haematological disorders.
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Research Support, Non-U.S. Gov't
  • Authors:
    Nathwani AC, Davidoff AM, Linch DC
  • Publication date:
    01/2005
  • Pagination:
    3, 17
  • Journal:
    British journal of haematology
  • Volume:
    128
  • Issue:
    1
  • Medium:
    Print
  • Status:
    Published
  • Print ISSN:
    0007-1048
  • Language:
    eng
  • Keywords:
    Animals, Humans, Hematologic Neoplasms, Hematologic Diseases, Hemophilia A, Severe Combined Immunodeficiency, Hematopoietic Stem Cell Transplantation, Transduction, Genetic, Genetic Vectors, Randomized Controlled Trials as Topic, Genetic Therapy
  • Addresses:
    Department of Haematology, University College London, London, UK. a.nathwani@ucl.ac.uk
Abstract
Gene therapy aims to correct the disease process by restoring, modifying or enhancing cellular functions through the introduction of a functional gene into a target cell. Whilst the concept of gene therapy is simple, the practical reality of translating this new technology to the clinic has proven to be more difficult than first imagined. Recent progress in gene transfer technology has shown impressive clinical success in infants with immunodeficiency. However, two of these children have subsequently developed leukaemia as a result of insertional mutagenesis, thus, raising important questions about the safety of genetic therapeutics. This article reviews the current status of gene therapy and outlines the challenges faced by this emerging technology that holds so much promise for many suffering from catastrophic disorders.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
There are no UCL People associated with this publication
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by